> Agile Therapeutics has named Al Altomari, a former senior manager at Johnson & Johnson who has been serving as Agile's executive chairman, will as successor to Thomas Rossi as president and
> Jean-Luc Bélingard, chairman and CEO of Ipsen, is leaving the company. Marc de Garidel has been named chairman and CEO to strengthen its U.S. and emerging markets operations. Ipsen
Vaccinogen has appointed veteran biotechnology executive Michael Kranda as president and CEO to guide it through its next stage of growth. Vaccinogen release NGM Biopharmaceuticals has named William
Creabilis has appointed Eliot Forster as its new CEO. Creabilis release Mersana Therapeutics has named Nicholas Bacopoulos as president and CEO. Bacopoulos succeeds Julie Olson, who has been
> FluoroPharma appoints Thijs Spoor as CEO and director. FluoroPharma release > Cmed has named of Andrew Kellett as CFO. Cmed release > Scott Biller will join Agios Pharmaceuticals as chief
> Marc Beer has joined Aegerion Pharmaceuticals as CEO and a member of the board of directors. Aegerion release > SARcode has announced that Quinton Oswald has joined the company as CEO.
> Humacyte has named Carrie Cox, formerly of Schering-Plough, as CEO. Humacyte release > Pevion Biotech AG has appointed Evert Kueppers as its new CEO, succeeding Thomas Stauffer. Pevion
> Theratechnologies has named John-Michel Huss as president and CEO. Theratechnologies release > During its first meeting, the board of directors of Pierre Fabre appointed Olivier Bohuon as the
NeuroSearch has named Patrik Dahlen as the new CEO of the company, replacing Flemming Pedersen, who has resigned to take up a new position in another company. NeuroSearch release Torbjorn Bjerke has
Amarin has tapped Colin Stewart as president, CEO and a member of the company's board of directors. Amarin release SkyePharma has appointed Axel Müller as CEO with effect from Aug. 23.